StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SKN.AX$0.01+0.00%
Fair $0.01+0.0%

SKN.AX

Skin Elements Limited

Consumer Defensive / Household & Personal ProductsASX

$0.01

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $0.01Fund rank 29/100 · Data gapFallback financials|
SA 32/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 33% · confianza 21%

FCF escenarios

weak_data · normalized FCF $-1.5M · quality 59.0/100

Data gap 29/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 23/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is 1.8%, below the 5% threshold
Thesis & Journal · SKN.AXLocal privado en este navegador · Skin Elements Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$18M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

181.3%

↑

Gross Margin

86.9%

↑

Debt/Equity

-0.03

↓
52-Week Range$0
$0$0

TradingView lightweight chart

SKN.AX price, volumen y niveles de valoración

Último $0.006Periodo -96.2%
Fair value: $0.006

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2021–2024 · 3 años de histórico normalizado

Revenue CAGR

+13.0%

FCF CAGR

—

FCF margin

-60.6%

FCF / Net income

0.13x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $416202.0 · net income $-1.9M · FCF $-252120.0

2021-FY → 2024-FY

Gross margin

86.9%+21.0% pts

Operating margin

-787.3%+630.4% pts

Net margin

-450.2%+603.5% pts

FCF margin

-60.6%+887.7% pts
MetricTTM
2024
2023
2022
2021
Income Statement
Revenue$416202.00$416202.00$194131.00$1.4M$288741.00
Net Income$-1.9M$-1.9M$-4.1M$-1.6M$-3.0M
EBITDA$-1.8M$-1.8M$-3.6M$-1.2M$-2.5M
EPS-0.00-0.00-0.01-0.00—
Gross Margin86.9%86.9%49.0%74.1%66.0%
Operating Margin-787.3%-787.3%-2602.1%-247.0%-1417.7%
Net Margin-450.2%-450.2%-2114.1%-115.2%-1053.7%
Balance Sheet
Debt/Equity-0.03-0.030.000.000.00
Current Ratio4.684.68———
Cash Flow
Free Cash Flow$-252120.00$-252120.00$-1.8M$-1.5M$-2.7M
Returns
ROE181.3%181.3%-50.7%-15.9%-31.7%
Valuation
P/B——0.451.634.42
Growth & Yield
Revenue Growth114.4%114.4%-86.2%387.7%—
EPS Growth64.9%64.9%-142.7%——

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +100.0%

Total return

+100.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.01 → -0.00

Residual

+100.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+100.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.